logo
Select company
Select metric
3.86Cash Ratio
VS
Market
90
Sector
82
Industry
73
History
59
$ 6.19Close
$ 5.02 - $ 21.59 52-Week Range
Ticker Information

Ticker

TRDA

Company Name

ENTRADA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENTRADA THERAPEUTICS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TRDA - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 76.43M3.86$ 19.8M
3/31/2025$ 71.79M3.89$ 18.43M
12/31/2024$ 105.16M2.66$ 39.48M
9/30/2024$ 82M1.16$ 70.6M
6/30/2024$ 189.2M2.2$ 85.81M
3/31/2024$ 72.39M0.42$ 173.94M
12/31/2023$ 71.55M0.45$ 158.8M
9/30/2023$ 55.83M0.34$ 165.43M
6/30/2023$ 83.69M0.66$ 125.94M
3/31/2023$ 231.6M1.57$ 147.59M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENTRADA THERAPEUTICS INC's latest trailing twelve months (TTM) Cash Ratio stands at 11.62.
  • Over the past 5 years, ENTRADA THERAPEUTICS INC's average Cash Ratio has been 7.52.
  • The median Cash Ratio for ENTRADA THERAPEUTICS INC during this period was 2.66
  • ENTRADA THERAPEUTICS INC reached its highest Cash Ratio over the past 5 years at 43.32.
  • The lowest Cash Ratio recorded by ENTRADA THERAPEUTICS INC in the same timeframe 0.34

ENTRADA THERAPEUTICS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
ALEC : ALECTOR INC 0.55SGMO : SANGAMO THERAPEUTICS INC 0.84ENTA : ENANTA PHARMACEUTICALS INC 1.01ADCT : ADC THERAPEUTICS SA 4.1CDXS : CODEXIS INC 1.86BDTX : BLACK DIAMOND THERAPEUTICS INC 1.83SCPH : SCPHARMACEUTICALS INC 2THTX : THERATECHNOLOGIES INC 0.24EDIT : EDITAS MEDICINE INC 2.1FENC : FENNEC PHARMACEUTICALS INC 2.22

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for ENTRADA THERAPEUTICS INC is calculated as follows: CashnEq [ $ 39.05M ] / LiabilitesC [ $ 3.36M ]
(=) Cash Ratio [ 11.62 ]

TRDA - Cash Ratio, Last 5 years

0.34

Minimum

Sep 30, 2023

43.32

Maximum

Dec 31, 2021

7.52

Average

2.66

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63